Ethicon
STRATAFIX™ Spiral Plus Devices transforms wound closure experience for
surgeons.
Ethicon has
launched Stratafix Spiral PDS Plus and Stratafix Spiral Monocryl Plus Knotless
Tissue Control Devices that provides a unique edge over traditional suturing.
Stratafix
sutures enables more strength, consistency, security and efficiency over its
predecessors because the surgeon can manage tension and control tissue
approximation with each pass. It also eliminates the need to tie knots.
Mayo Clinic
Tampon Test for detecting Endometrial Cancer at early stage.
There is no
standard screening test to identify endometrial cancer, hence it is often
detected late when the disease has already advanced.
Mayo clinic
expert Jamie N. Bakkum-Gamez, M.D. and her team are in the process of
developing a simple screening test that can be done at home using a tampon. It
is based on the concept of detecting tumor DNA hypermethylation in vaginal pool
DNA picked up by ordinary tampon.
At last, a
no surgery, no knife, noninvasive treatment for uterine fibroid receives
European approval.
Mirabilis
Medical, a Seattle based company received CE Mark authorization for marketing of
the Mirabilis System for treatment of uterine fibroids throughout the European
Union. It also announced that it had
received a green signal from US-FDA to begin its clinical studies in US.
The
Mirabilis system is a High-Intensity Focused Ultrasound (HIFU) system consists
of an ultrasound system that has two parts: the imaging part and the therapy
part.
Synthetic
progestogens, but not natural progesterone, lowers miscarriage risk among women
with unexplained RPL: Systematic review and meta-analysis.
Women taking
progestogens have a 28% lower risk of miscarriage (RR 0.72; 95% CI
0.53-0.97). and 7% higher chances of
live births as compared to women who did not receive any supplementation. (RR
1.07, 95% CI 1.02–1.15).
The
Meta-analysis included 10 trials comprising a total of 1,586 women with history
of recurrent miscarriage.
Sperms used
as vehicle for targeted drug delivery in gynecological cancers.
Sperms are
not just for baby-making anymore, but can be used as cargo agents for
delivering drugs inside the body.
Getting the
chemotherapeutic agent to only kill the tumor cells without affecting the
normal cells is a dream come true in area of cancer therapeutics because of
Targeted drug delivery systems(TDDS).
Targeted
drug delivery systems using polymeric nanoparticles have opened up new avenues
in cancer chemotherapy. Liposomes have
shown to be effective among an array of nano- and microcarriers but have the
drawback of dilution by body fluids, decreased penetration and uptake by
non-target tissues.
